يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"Ferraccioli, Gianfranco"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, SEBASTIANI, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthriti, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; https://hdl.handle.net/11381/2977650Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    https://hdl.handle.net/11381/2977650Test

    View record in BASE

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11577/3277137Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11577/3277137Test

    View record in BASE

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Ramonda, Roberta, Lapadula, Giovanni, Bergossi, Francesca, SEBASTIANI, Marco

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11380/1138105Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11380/1138105Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    Drug survival of adalimumab in patients with rheumatoid arthritis over 10Â years in the real-world settings: high rate remission together with normal function ability

    المؤلفون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    المساهمون: Iannone, Florenzo, Sinigaglia, Lugi, Favalli, Ennio Giulio, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola, Caporali, Roberto, Codullo, Veronica, Ferraccioli, Gianfranco, Gremese, Elisa, Carletto, Antonio, Giollo, Alessandro, Govoni, Marcello, Bergossi, Francesca, Galeazzi, Mauro, Cantarini, Luca, Salaffi, Fausto, Di Carlo, Marco, Bazzani, Chiara, Pellerito, Raffaele, Sebastiani, Marco, Ramonda, Roberta, Lapadula, Giovanni

    مصطلحات موضوعية: Drug survival, GISEA, HAQ, LORHEN, Activities of Daily Living, Adalimumab, Adult, Aged, Antirheumatic Agent, Arthritis, Rheumatoid, Biological Product, Disease Progression, Female, Human, Male, Middle Aged, Registrie, Remission Induction, Treatment Outcome, Rheumatology

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27418051; info:eu-repo/semantics/altIdentifier/wos/WOS:000386362000003; volume:35; issue:11; firstpage:2649; lastpage:2656; numberofpages:8; journal:CLINICAL RHEUMATOLOGY; http://hdl.handle.net/11570/3125483Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978828157; link.springer.de/link/service/journals/10067/index.htm

    الإتاحة: https://doi.org/10.1007/s10067-016-3349-zTest
    http://hdl.handle.net/11570/3125483Test

    View record in BASE

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Longterm retention of tumor necrosis factor-α inhibitor therapy in a large Italian cohort of patients with rheumatoid arthritis from the GISEA Registry: An appraisal of predictors

    المؤلفون: Iannone, Florenzo, Gremese, Elisa, Atzeni, Fabiola, Biasi, Domenico, Botsios, Costantino, Cipriani, Paola, Ferri, Clodoveo, Foschi, Valentina, Galeazzi, Mauro, Gerli, Roberto, Giardina, Annarita, Marchesoni, Antonio, Salaffi, Fausto, Ziglioli, Tamara, Lapadula, Giovanni, Bambara, Maria Lisa, Cantini, Fabrizio, Ferraccioli, Gianfranco, Foti, Rosario, Giacomelli, Roberto, Gorla, Roberto, Grassi, Walter, Mathieu, Alessandro, Olivieri, Ignazio, Passiu, Giuseppe, Punzi, Leonardo, Salvarani, Carlo, Sarzi-Puttini, Piercarlo, Scarpa, Raffaele, Triolo, Giovanni, Trotta, Francesco

    المساهمون: Iannone, Florenzo, Gremese, Elisa, Atzeni, Fabiola, Biasi, Domenico, Botsios, Costantino, Cipriani, Paola, Ferri, Clodoveo, Foschi, Valentina, Galeazzi, Mauro, Gerli, Roberto, Giardina, Annarita, Marchesoni, Antonio, Salaffi, Fausto, Ziglioli, Tamara, Lapadula, Giovanni, Bambara, Maria Lisa, Cantini, Fabrizio, Ferraccioli, Gianfranco, Foti, Rosario, Giacomelli, Roberto, Gorla, Roberto, Grassi, Walter, Mathieu, Alessandro, Olivieri, Ignazio, Passiu, Giuseppe, Punzi, Leonardo, Salvarani, Carlo, Sarzi-Puttini, Piercarlo, Scarpa, Raffaele, Triolo, Giovanni, Trotta, Francesco

    مصطلحات موضوعية: Adalimumab, Drug survival, Etanercept, Infliximab, Antibodies, Monoclonal, Humanized, Antirheumatic Agent, Arthralgia, Arthritis, Rheumatoid, Biomarker, Drug Substitution, Female, Health Statu, Human, Immunoglobulin G, Italy, Joint, Kaplan-Meier Estimate, Male, Middle Aged, Pain Measurement, Prospective Studie, Receptors, Tumor Necrosis Factor, Survival Rate, Time Factor, Tumor Necrosis Factor-alpha, Registrie

    وصف الملف: ELETTRONICO

    العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22467933; info:eu-repo/semantics/altIdentifier/wos/WOS:000304893800014; volume:39; issue:6; firstpage:1179; lastpage:1184; numberofpages:6; journal:THE JOURNAL OF RHEUMATOLOGY; http://hdl.handle.net/11570/3125362Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84861811932; http://www.jrheum.org/content/39/6/1179.full.pdf+htmlTest

    الإتاحة: https://doi.org/10.3899/jrheum.111125Test
    http://hdl.handle.net/11570/3125362Test
    http://www.jrheum.org/content/39/6/1179.full.pdf+htmlTest

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث